Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Ready for the next step.
View:
Post by Lesalpes29 on Nov 20, 2022 7:34am

Ready for the next step.

Not sure what will be announced in the near futur. Buyout or a deeper partnership with money upfront with a BP. But the addition of Mr Parsons and Mr Rigby are a clear sign that negociations are on and with more than one possible partner or buyer. I stick with that at the moment and when the SP is going under 1.90 I'm buying some like friday at 1.88. I could be wrong of course but I can't believe the new directors are in to do f...all! Have a great Sunday,
Comment by fox7mf on Nov 20, 2022 8:37am
Great post & 100% agreed. Westcoast1000 also presented very astute pts lending credence to a possible 2022 acquisition. The conversation around here of late, aside from the obvious detractors, has been suitably confident & constructive. My opinion is still that Roche may have already presented a proposal & Onc is anxiously waiting for what Pfizer has to say at the end of their 90 day ...more  
Comment by inthno on Nov 20, 2022 11:13am
Hello and I like your thinking Fox7mf by my question in regards to that is that I thought that a public company if presented with a reasonalbe offer has to present it to shareholders. I am not sure you can just put a waiting period on the offer. It has been suggested in the past that onc has had offers and rejected them as they did not deem them suitable to present to shareholders. I would think ...more  
Comment by canadafan on Nov 20, 2022 11:52am
I like the question regarding public company & fair offers etc. I have the privlage of previous ownership of public companies that were bought out. There are multiple paths, but generally go like this. 1. An agreement to get into a deal, happens verbally, at the CEO, very senior level. 2. An offer is drafted & presented to senior levels. Minor fine tuning.  3. That could include ...more  
Comment by askretka on Nov 20, 2022 9:58pm
CAR-T study by Dr Vile at Mayo Clinic came from Dr. Vile looking at AWARE-1 data early on, that was mentioned by Matt in a quarterly webcast over a year ago. So it might be another reason that Roche would go for CAR-T as well because the experiment was a spin off from their AWARE-1 study and they have the data and are more AWARE of the potential. Pun intended Cheers!!!!!!!!!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities